Nezam El-Tayebat Fact CheckA scientific assessment of the “نظام الطيبات” nutrition system
Choose country
Choose language: English

Mostly false Scientifically refuted Certainty of evidence: moderate provisional C-BAR-01

Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

Safety note: Decisions about bariatric surgery should be made with a qualified multidisciplinary team (NICE NG246; ASMBS/IFSO 2022). Severe obesity itself carries high mortality (BMI 40+ about 2.8-fold, I-BAR-10). People who have had surgery should not stop follow-up, prescribed supplements or treatment based on this claim; lifelong follow-up including mental-health and alcohol screening is recommended.
In short: This claim is false as a general statement. Large matched studies, including sleeve-specific data, show lower rather than higher mortality after bariatric surgery than in comparable people with severe obesity, and death from the operation itself is rare (about 0.05% for sleeve); real but uncommon fatal risks (complications, suicide, alcohol) exist and require lifelong follow-up.
Conclusion: As a general statement this is false: on average, bariatric surgery including sleeve is associated with lower mortality and longer life in severe obesity, and death from the operation itself is rare (about 1 in 2,000 sleeves); specific rare fatal risks (complications, suicide, alcohol) exist.
  1. Original statement
  2. Scientific assessment
  3. Scientific evidence in detail
  4. In plain language
  5. Studies on this claim
  6. Regional context
  7. What applies in my country?
  8. References

Original statement

تكميم اه قاتل قاتل قاتل قاتل قاتل

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

Origin

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr Diaa Al Awady د ضياء العوضي is live!لايف مش مهم خالص (Open source)
Published
11 February 2026
Timestamp
0:58:06 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
Claimed mechanism

Removing most of the stomach destroys its function and leads to disease and death.

Claimed health effect

Death; shortened life.

Population concerned

People with obesity considering surgery

Geographic restriction by Elawady

none found

Diverging source versions

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
الخوف حقيقه ام سراب. أضرار التكميم. بين الحقيقه والسراب (Open source)
Published
19 November 2025
Timestamp
not available (transcript has no timings)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr Diaa Al Awady د ضياء العوضي is live! الموت المفاجيء (Open source)
Published
14 July 2025
Timestamp
not available (transcript has no timings)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
Source status
Archive quote (no location given)
Attribution
Elawady (archive paraphrase; source video not given)
Origin
https://eltayebat.com/rule/bariatric-surgery/
Attribution uncertainty
The archive attributes this wording to Dr. Diaa but gives no video reference.

Scientific assessment

Mostly false – Essential parts of the statement are not supported by the evidence or are strongly exaggerated.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

That sleeve/bariatric surgery is 'lethal' and kills patients.

2. What is demonstrably correct?

Deaths after bariatric surgery do occur: early postoperative mortality is about 0.04-0.3% in large registries/cohorts, and long-term deaths from accidents, suicide and alcohol are more frequent than in non-operated people with obesity (Adams 2007: 11.1 vs 6.4 per 10,000 person-years; SOS 2020: HR 1.85).

3. What is wrong or exaggerated?

As a general statement it is contradicted: overall mortality is lower after surgery (SOS HR 0.77 over 24 years; Adams 40% lower; meta-analysis about 49% lower hazard and +6.1 years median life expectancy, with no difference between sleeve, bypass and banding).

4. What remains unclear?

No randomized trial of survival exists; residual confounding could inflate the benefit. Sleeve-specific very-long-term (>20 years) survival data are limited.

5. Which studies support it?

A-BAR-03 (excess non-disease deaths). A-BAR-16 and I-BAR-104 document increased suicide after surgery (Nordic suicide HR 1.68), and I-BAR-141 found no proven survival benefit in cohorts below median age, with more external-cause deaths. The Egyptian series I-BAR-105 reported 2 deaths in 892 sleeve operations (0.22%). None of these shows overall life-shortening.

6. Which studies contradict it?

A-BAR-01, A-BAR-02, A-BAR-05, A-BAR-12, I-BAR-01; sleeve-specific: I-BAR-101 (Israel, sleeve vs usual care HR about 0.62) and I-BAR-102 (USA, sleeve HR 0.28 at 5 years); perioperative meta-analysis I-BAR-103 (sleeve 0.05%); guidelines I-BAR-107 (NICE NG246), I-DIAB-113 (ADA 2026), I-BAR-11 (ASMBS/IFSO 2022).

7. What applies to Germany and Europe?

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

8. What is known about Egypt?

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

9. What practical conclusion is appropriate?

Bariatric surgery carries real risks, including rare early deaths and an increased risk of suicide, accidents and alcohol problems, but on average it is associated with longer survival in severe obesity.

Assessment details

Rationale for certainty of evidence

Survival data are observational (long-term RCT evidence on mortality is very uncertain, I-BAR-143), but large, consistent and long-term: SOS 24 years, an individual-level meta-analysis of 174,772 people including sleeve (I-BAR-01), and sleeve-specific matched cohorts from Israel and the USA (I-BAR-101, I-BAR-102). Perioperative mortality is directly measured and low (sleeve about 0.05%, I-BAR-103).

Source quality

Elawady's statement is a verbal assertion without cited data. Counter-evidence comes from prospective cohorts, registries and a meta-analysis.

Regional transferability

European data (Sweden) are direct.

Individual exceptions

Individual deaths from complications do occur; risk is higher with complications, poor follow-up, alcohol misuse, or severe comorbidity.

Regional scope of the claim
general (biological/medical)
Last reviewed
26 October 2026 provisional

Scientific evidence in detail

Scientifically refuted – High-quality evidence shows the opposite, or the claim contradicts well-established physiology.

Research question: In adults with severe obesity, is sleeve gastrectomy (or bariatric surgery in general) associated with higher all-cause mortality or shorter life than comparable non-operated people?

Research question in detail (PICO)
Population
Adults with severe obesity (BMI >=35-40) eligible for bariatric surgery
Intervention or exposure
Sleeve gastrectomy; other bariatric procedures
Comparison
Matched non-operated people with obesity (usual care); general population for context
Geographic scope
universal biology; health-system quality (surgical volume, follow-up) modifies risk
Outcomes
  • All-cause mortality
  • Perioperative (30/90-day) mortality
  • Cause-specific mortality (suicide, alcohol, external causes)
  • Life expectancy

Study results as reported by the authors. Our assessment follows below.

What speaks for the claim?

  • Nordic study: survival after obesity surgery

    Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048 Cohort studyabstract checkednewly added

    Nordic registry study: operated patients still died about twice as often as the general population, and suicide deaths were higher than in obese non-operated people.

    Actual result
    SMR 1.94 (1.83-2.05), 2.28 at >=15 y; suicide HR 1.68 (1.32-2.14); but all-cause HR 0.63 (0.60-0.66) vs obese non-operated.
    Methodological quality
    moderate (large registry cohort)
    Relevance
    indirect - supports only the existence of specific excess causes of death, not overall life-shortening; mostly older procedures
    Limitations
    Registry confounding; few sleeve operations

    Original publication

  • Meta-analysis: does surgery prolong life at every age?

    Pontiroli et al.. Obes Surg 2020 · PMID 32152843 · DOI 10.1007/s11695-020-04530-3 Meta-analysisabstract checkednewly added

    Meta-analysis: survival benefit of surgery was not demonstrated in cohorts below median age, and external-cause deaths were more frequent after surgery.

    Actual result
    OR below median age 0.78 (0.57-1.06); above median age 0.23 (0.12-0.44).
    Methodological quality
    moderate (meta-analysis of observational studies)
    Relevance
    direct for young patients - limits the general benefit argument, does not show net harm
    Limitations
    Study-level age split

    Original publication

  • Gastric bypass: fewer deaths overall, but more accident and suicide deaths

    Adams TD et al.. N Engl J Med 2007 · PMID 17715409 · DOI 10.1056/NEJMoa066603 Cohort studyabstract checked

    Utah cohort: deaths not caused by disease (accidents, suicide) were 58% higher after gastric bypass.

    Actual result
    11.1 vs 6.4 per 10,000 person-years; overall mortality 40% lower.
    Methodological quality
    moderate
    Relevance
    indirect (gastric bypass)
    Limitations
    Older procedure

    Original publication

What speaks against the claim?

What does the overall evidence say?

Editorial assessment based on the studies above – not itself a study result.

Which position is better supported?

Bariatric surgery, including sleeve gastrectomy, is associated on average with lower mortality and longer life than continued severe obesity; early surgical death is rare (about 1 in 2,000 sleeves).

Why some studies weigh more

Large matched cohorts and an individual-participant meta-analysis with consistent direction outweigh mechanistic assertions; sleeve-specific cohorts (I-BAR-101, I-BAR-102) are given high weight for directness. The Cochrane NMA (I-BAR-143) shows RCT evidence on mortality is very uncertain because trials are small, so certainty rests on observational data.

Is a causal relationship established? Probable Consistent large effects, dose-response with weight loss and plausible mechanisms; residual confounding (healthy-user effect) cannot be excluded without long-term RCTs.

Remaining uncertainty

Very long-term (>15 y) sleeve-specific survival; net effect in young adults; real excess of suicide and alcohol deaths.

Justified conclusion

The claim that sleeve gastrectomy is lethal or shortens life is false as a general statement; specific, rare fatal risks exist and require follow-up.

Why do studies seem to disagree?

Studies with the general population as reference (SMR ~2, I-BAR-104; A-BAR-05 5.5 years shorter) and studies with obese non-operated controls (HR 0.5-0.8) answer different questions and do not conflict: operated people remain at higher risk than the general population but at lower risk than comparable people with obesity. Excess external-cause deaths (suicide, alcohol) coexist with large reductions in cardiovascular, cancer and diabetes deaths. Lack of benefit in young cohorts (I-BAR-141) reflects lower baseline risk and more external-cause deaths, not overall harm.

Does this depend on the country?
General biological effects
Effect of surgery on survival is biological and procedure-related; universal.
Eating habits
Not applicable (surgical procedure, not a food).
Origin of the food
Not applicable (surgical procedure, not a food).
Contaminants
Not applicable (surgical procedure, not a food).
National production conditions
Elawady states sleeve is very common in Egypt; perioperative risk depends on surgical volume and quality, which may vary between centres.
Legal rules
Not applicable.
Actual monitoring data
No Egyptian national bariatric registry data were found; one Egyptian single-surgeon series (I-BAR-105) and one Egyptian RCT (I-BAR-136) were identified. The Egyptian series reported 0.22% 30-day mortality (2/892), within the range of international data but imprecise.

A regional difference that changes the conclusion is not supported by robust data.

Statistical re-check
  • HR direction (reported as nonsurgical vs surgical) and CI symmetry; crude absolute risk for sleeve – Inverted HR surgery vs control: overall 0.50 (0.40-0.61), sleeve 0.62 (0.40-0.98); CIs log-symmetric; crude sleeve ARR 0.5 percentage points over ~3 y (reported 1.8 fewer deaths/1000 person-years). recalculated
  • CI symmetry and unadjusted ARR/NNT – SG HR 0.28 CI log-symmetric (ratio 1.08); unadjusted 5-y ARR 1.7 percentage points (NNT ~58, observational). recalculated
  • Translate pooled perioperative mortality into absolute frequencies; compare Egyptian series – Sleeve 0.05% = about 1 death per 2,000 operations; Egyptian series 0.22% (2/892). recalculated
  • CI symmetry; SMR vs HR interpretation – All CIs log-symmetric; SMR (vs general population) and HR (vs obese controls) answer different questions. recalculated
Certainty of the overall evidence (GRADE, simplified)
Main outcome
All-cause mortality after bariatric surgery (incl. sleeve) vs usual care
Starting level
low (observational studies)
Reasons for downgrading
  • risk of bias: observational, residual confounding (not downgraded further because of consistency of matched designs)
Reasons for upgrading
  • large effect (HR ~0.5)
  • consistency across countries and procedures
Result
moderate

Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.

Clinical guidelines and official statements checked
  • NICE: Overweight and obesity management (NG246), section 1.18 Bariatric surgery (2025 (last updated 8 Jan 2026)) · Original publication
    Offer referral for bariatric surgery assessment with BMI >=40, or 35-39.9 with a significant weight-related condition, if the person agrees to lifelong follow-up; lower thresholds by 2.5 for people of Middle Eastern, South Asian, Chinese and Black African/Caribbean background; follow-up >=2 years in the bariatric service and at least annual nutritional monitoring and supplementation afterwards.
  • NICE: Obesity: identification, assessment and management (CG189) (2014 (last updated 2023)) · Original publication
    Page states that CG189 has been updated and replaced by NICE guideline NG246; content therefore taken from NG246.
  • ASMBS/IFSO: 2022 ASMBS and IFSO Indications for Metabolic and Bariatric Surgery (I-BAR-11) (2022) · Original publication
    Metabolic and bariatric surgery is recommended for BMI >35 regardless of comorbidities and should be considered for BMI 30-34.9 with metabolic disease; long-term results consistently demonstrate safety and efficacy (abstract; erratum noted in PubMed).
  • ADA: Standards of Care in Diabetes-2026, Section 8 (I-DIAB-113) (2026) · Original publication
    Consider metabolic surgery in type 2 diabetes with BMI >=30 (>=27.5 Asian American) (A); long-term medical and behavioural support with routine micronutrient and metabolic monitoring (B); routine psychosocial screening after surgery (C); text cites lower relapse after RYGB than sleeve (5-y relapse 33.1% vs 41.6%).
  • AACE/TOS/ASMBS/OMA/ASA: Clinical Practice Guidelines for Perioperative Nutrition, Metabolic and Nonsurgical Support (I-BAR-09) (2019) · Original publication
    Executive summary: bariatric procedures remain a safe and effective intervention for higher-risk patients with obesity; a team approach to perioperative care is mandatory, with special attention to nutritional and metabolic issues (abstract).
Search strategy

Documented literature searches for this review (search strings in the original database syntax).

DatabaseDateSearchLooking forHitsIncluded
PubMed26 October 2026(bariatric surgery[tiab] OR sleeve gastrectomy[tiab]) AND (increased mortality[ti] OR excess mortality[ti] OR "mortality" [ti]) AND (external causes OR suicide OR accidents OR younger OR late mortality)supporting evidence43
Europe PMC26 October 2026TITLE:"bariatric" AND (TITLE:"cause-specific mortality" OR TITLE:"excess mortality" OR TITLE:"late mortality" OR TITLE:"external causes")supporting evidence3
Europe PMC26 October 2026(TITLE:"bariatric" OR TITLE:"sleeve gastrectomy" OR TITLE:"metabolic surgery") AND (TITLE:"mortality" OR TITLE:"survival" OR TITLE:"life expectancy") AND (PUB_TYPE:"Meta-Analysis" OR TITLE:"meta-analysis") AND PUB_YEAR:[2019 TO 2026]contradicting evidence14
Europe PMC26 October 2026(TITLE:"sleeve gastrectomy") AND (TITLE:"mortality" OR TITLE:"survival") AND (TITLE:"usual care" OR TITLE:"nonsurgical" OR TITLE:"matched" OR TITLE:"cohort")contradicting evidence4
PubMed26 October 2026(sleeve gastrectomy[ti] OR bariatric[ti]) AND (all-cause mortality[ti] OR long-term mortality[ti]) AND (usual care OR nonsurgical OR matched controls)contradicting evidence9
Europe PMC26 October 2026AFF:"Egypt" AND (TITLE:"sleeve gastrectomy" OR TITLE:"bariatric") AND (TITLE:"mortality" OR TITLE:"complications" OR TITLE:"deficiency" OR TITLE:"anemia")both directions19
Europe PMC26 October 2026JOURNAL:"Cochrane Database Syst Rev" AND (TITLE:"surgery for weight loss" OR TITLE:"bariatric" OR TITLE:"obesity surgery" OR TITLE:"surgery for obesity")guidelines13
Web (guideline site)26 October 2026https://www.nice.org.uk/guidance/cg189 ; https://www.nice.org.uk/guidance/ng246 ; .../chapter/Medicines-and-surgeryguidelines
Web (guideline site)26 October 2026https://pmc.ncbi.nlm.nih.gov/articles/PMC12690172/ (ADA Standards of Care 2026, section 8)guidelines

Open questions

Sleeve-specific survival beyond 15 years; outcomes in Egyptian practice (no national registry found).

How deeply was this checked?

18 linked studies: 7 checked in full text (3 of them with a structured risk-of-bias assessment), 11 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

History of the verdict
  1. 25 October 2026 · Phase 1 · Initial assessment: Mostly false (moderate)
  2. 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: Mostly false (moderate)
    Verdict and certainty unchanged. New sleeve-specific mortality cohorts (I-BAR-101, I-BAR-102) and a perioperative meta-analysis (I-BAR-103) strengthen the contradicting evidence; new limiting evidence (I-BAR-104, I-BAR-141, I-BAR-143) confirms real excess external-cause deaths, no proven benefit in young cohorts and very uncertain RCT data, which justifies keeping “Mostly false” rather than “False” and certainty at moderate.
    New sources: I-BAR-101 I-BAR-102 I-BAR-103 I-BAR-107 I-DIAB-113 I-BAR-104 I-BAR-105 I-BAR-141 I-BAR-143

In plain language

Elawady called sleeve gastrectomy 'lethal'. Large studies do not support this as a general statement. People who had weight-loss surgery lived longer on average than similar people who did not: in Sweden about 3 years longer, in a large meta-analysis about 6 years longer. Deaths within the first weeks after surgery are rare (well below 1%). However, there is a real increase in deaths from suicide, accidents and alcohol after surgery, so mental-health follow-up is important.

Studies on this claim

Studies supporting the claim (1)

  • Gastric bypass: fewer deaths overall, but more accident and suicide deaths

    Adams TD et al.. N Engl J Med 2007 · PMID 17715409 · DOI 10.1056/NEJMoa066603
    Cohort studycited by the Tayebat archiveabstract checked★ key study

    Total deaths were 40% lower after surgery, while deaths from accidents and suicide were higher (11.1 vs 6.4 per 10,000 person-years).

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Long-term mortality

    How was the study done?

    Matched retrospective cohort

    How many people, animals or samples were studied?

    15,850 people

    What was actually found?

    Total deaths down, external-cause deaths up

    How large was the observed effect?

    37.6 vs 57.1 total; 11.1 vs 6.4 non-disease per 10,000 PY

    What do the results mean in everyday life?

    Net survival benefit with a specific mental health and accident risk

    What are the study's limitations?

    Observational

    What does it say about Elawady's specific claim?

    Supports self-harm concern, contradicts 'lethal'

    Do the results apply to Germany and Europe?

    Comparable to Nordic findings

    What can explicitly not be concluded from this study?

    Causation of suicide excess

    Scientific details →

Studies contradicting or limiting the claim (11)

  • Short-term safety of weight-loss surgery in the US

    Flum DR et al.. N Engl J Med 2009 · PMID 19641201 · DOI 10.1056/NEJMoa0901836
    Cohort studycited by the Tayebat archivefull text, structured risk-of-bias assessment

    About 3 in 1000 patients died within 30 days; 4.3% had a serious complication.

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Measure early risks

    How was the study done?

    Prospective multicentre cohort

    How many people, animals or samples were studied?

    4776 adults

    What was actually found?

    Low early mortality (0.3%)

    How large was the observed effect?

    30-day death 0.3%

    What do the results mean in everyday life?

    Serious early complications are uncommon but real

    What are the study's limitations?

    Only 30 days; sleeve operations excluded; experienced centres; no non-surgical comparison

    What does it say about Elawady's specific claim?

    Does not support 'lethal'; documents a small real risk

    Do the results apply to Germany and Europe?

    Similar to European data

    What can explicitly not be concluded from this study?

    Long-term effects

    Scientific details →

  • Swedish study: fewer deaths after weight-loss surgery

    Sjöström L et al.. N Engl J Med 2007 · PMID 17715408 · DOI 10.1056/NEJMoa066254
    Cohort studycited by the Tayebat archiveabstract checked

    Over about 11 years, people who had surgery had roughly 24-29% lower risk of dying than matched controls.

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Test mortality effect

    How was the study done?

    Prospective matched study

    How many people, animals or samples were studied?

    4047 adults

    What was actually found?

    Fewer deaths after surgery

    How large was the observed effect?

    Adjusted HR 0.71

    What do the results mean in everyday life?

    Surgery was linked to living longer

    What are the study's limitations?

    Not randomized; older techniques

    What does it say about Elawady's specific claim?

    Argues against 'surgery kills'

    Do the results apply to Germany and Europe?

    Directly European

    What can explicitly not be concluded from this study?

    Exact causal size

    Scientific details →

  • Swedish 24-year study: surgery added about 3 years of life

    Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449
    Cohort studycited by the Tayebat archivefull text checked★ key study

    Operated patients lived about 3 years longer than non-operated patients with obesity, but still about 5.5 years less than the general population (non-operated: about 8.5 years less).

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Life expectancy

    How was the study done?

    Prospective controlled cohort with population reference

    How many people, animals or samples were studied?

    5182 people

    What was actually found?

    Surgery gained 3 years; gap to population 5.5 vs 8.5 years

    How large was the observed effect?

    HR death 0.77; +3.0 years

    What do the results mean in everyday life?

    Surgery reduced but did not remove the life-expectancy loss linked to severe obesity

    What are the study's limitations?

    Not randomized; old operations

    What does it say about Elawady's specific claim?

    Number correct, implication 'surgery shortens life' wrong

    Do the results apply to Germany and Europe?

    Directly European

    What can explicitly not be concluded from this study?

    That surgery causes the remaining 5.5-year gap

    Scientific details →

  • Swedish registry: early complications after bypass

    Stenberg E et al.. Ann Surg 2014 · PMID 24374541 · DOI 10.1097/SLA.0000000000000431
    Cohort studycited by the Tayebat archiveabstract checked

    Serious complications 3.4%; deaths within 90 days 4 in 10,000.

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Early risks

    How was the study done?

    Registry

    How many people, animals or samples were studied?

    26,173

    What was actually found?

    Low mortality

    How large was the observed effect?

    0.04%

    What do the results mean in everyday life?

    Death from the operation is rare

    What are the study's limitations?

    Short-term

    What does it say about Elawady's specific claim?

    Contradicts 'lethal'

    Do the results apply to Germany and Europe?

    European

    What can explicitly not be concluded from this study?

    Long-term harms

    Scientific details →

  • Meta-analysis: weight-loss surgery and survival

    Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
    Meta-analysisindependent cross-checkabstract checked★ key study

    Across 174,772 people, surgery was linked to about half the risk of death and about 6 more years of median life expectancy; sleeve showed similar effects to bypass.

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Survival

    How was the study done?

    Meta-analysis of matched cohorts

    How many people, animals or samples were studied?

    174,772

    What was actually found?

    Lower mortality

    How large was the observed effect?

    HR ~0.51; +6.1 years

    What do the results mean in everyday life?

    Surgery is linked to longer, not shorter, life in severe obesity

    What are the study's limitations?

    Observational studies

    What does it say about Elawady's specific claim?

    Contradicts 'lethal'

    Do the results apply to Germany and Europe?

    Includes Europe

    What can explicitly not be concluded from this study?

    Exact causal size

    Scientific details →

  • Body weight and death risk worldwide

    Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1
    Meta-analysisindependent cross-checkfull text, structured risk-of-bias assessment

    Severe obesity (BMI 40+) was linked to nearly 3 times the death risk of normal weight.

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    BMI-mortality

    How was the study done?

    IPD meta-analysis

    How many people, animals or samples were studied?

    ~4 million

    What was actually found?

    Higher BMI, higher mortality

    How large was the observed effect?

    HR 2.76 grade 3

    What do the results mean in everyday life?

    Severe obesity itself shortens life

    What are the study's limitations?

    Observational

    What does it say about Elawady's specific claim?

    Context for SOS gap

    Do the results apply to Germany and Europe?

    Includes Europe

    What can explicitly not be concluded from this study?

    Effect of weight loss

    Scientific details →

  • Israeli study: deaths after sleeve, bypass and banding vs usual care

    Reges et al.. JAMA 2018 · PMID 29340677 · DOI 10.1001/jama.2017.20513
    Cohort studyindependent cross-checkfull text checked★ key study

    People who had surgery, including sleeve, died less often over about 4 years than similar people with obesity who did not (sleeve 0.8% vs 1.3%).

    Sleeve-specific lower mortality vs usual care.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Compare death rates after three operations with usual care

    How was the study done?

    Matched cohort from health-fund records

    How many people, animals or samples were studied?

    8,385 operated, 25,155 controls

    What was actually found?

    Lower mortality with every operation, including sleeve

    How large was the observed effect?

    Sleeve: HR about 0.62 (surgery vs control)

    What do the results mean in everyday life?

    On average, sleeve did not shorten life in the first years

    What are the study's limitations?

    Observational; short follow-up for sleeve

    What does it say about Elawady's specific claim?

    Contradicts "sleeve is lethal"

    Do the results apply to Germany and Europe?

    Health-system data from Israel; plausible for Europe

    What can explicitly not be concluded from this study?

    Cannot prove causation or show very long-term effects

    Scientific details →

  • US study: survival after sleeve and bypass

    Courcoulas et al.. Ann Surg 2023 · PMID 34387200 · DOI 10.1097/SLA.0000000000005155
    Cohort studyindependent cross-checkfull text checked★ key study

    Over 5 years, people who had a sleeve died about 70% less often than similar people who did not have surgery (1.0% vs 2.7%).

    SG associated with lower 5-y mortality.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Compare deaths after SG/RYGB with matched non-operated patients

    How was the study done?

    Matched cohort, health records

    How many people, animals or samples were studied?

    13,900 SG; 17,258 RYGB; 87,965 controls

    What was actually found?

    Lower death rates after both operations

    How large was the observed effect?

    SG HR 0.28 (0.13-0.57)

    What do the results mean in everyday life?

    Sleeve was not associated with earlier death

    What are the study's limitations?

    About one third lost to follow-up; observational

    What does it say about Elawady's specific claim?

    Contradicts "sleeve kills"

    Do the results apply to Germany and Europe?

    Plausible for Europe and Egypt

    What can explicitly not be concluded from this study?

    Cannot exclude unmeasured confounding

    Scientific details →

  • How often people die from weight-loss surgery itself

    Robertson et al.. Br J Surg 2021 · PMID 34297806 · DOI 10.1093/bjs/znab245
    Meta-analysisindependent cross-checkabstract checked★ key study

    About 1 in 2,000 sleeve operations ends in death around the time of surgery.

    Early surgical mortality is rare (~0.05% for sleeve), so "lethal operation" is not supported; deaths do occur.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Measure early death risk

    How was the study done?

    Meta-analysis

    How many people, animals or samples were studied?

    >3.6 million patients

    What was actually found?

    Overall 0.08%, sleeve 0.05%

    How large was the observed effect?

    0.05% for sleeve

    What do the results mean in everyday life?

    Death from the operation is rare but not zero

    What are the study's limitations?

    Reporting differences between sources

    What does it say about Elawady's specific claim?

    Contradicts "lethal" as a general statement

    Do the results apply to Germany and Europe?

    Mostly Western data

    What can explicitly not be concluded from this study?

    Long-term mortality

    Scientific details →

  • UK NICE guideline on obesity surgery

    NICE. National Institute for Health and Care Excellence 2025
    Guideline / position statementindependent cross-checkabstract checked★ key study

    NICE recommends considering surgery for people with severe obesity and requires lifelong yearly checks of nutrition.

    Guideline recommends surgery for defined adults.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Guide care

    How was the study done?

    Guideline

    How many people, animals or samples were studied?

    not applicable

    What was actually found?

    Surgery is an option; lifelong follow-up

    How large was the observed effect?

    not applicable

    What do the results mean in everyday life?

    Surgery needs lifelong aftercare

    What are the study's limitations?

    National context

    What does it say about Elawady's specific claim?

    Contradicts "lethal", supports "lifelong supplements"

    Do the results apply to Germany and Europe?

    UK

    What can explicitly not be concluded from this study?

    Individual decisions

    Scientific details →

  • US diabetes standards 2026: weight loss and type 2 diabetes

    American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care 2026 · PMID 41358882 · DOI 10.2337/dc26-S008
    Guideline / position statementindependent cross-checkfull text checked★ key study

    Losing more than 10% of body weight can lead to remission of type 2 diabetes and reduce the need for insulin.

    Recommends metabolic surgery as an option.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Guide weight management.

    How was the study done?

    Guideline.

    How many people, animals or samples were studied?

    Not applicable.

    What was actually found?

    Weight loss >10% may induce remission.

    How large was the observed effect?

    Not applicable.

    What do the results mean in everyday life?

    Weight loss is a powerful treatment for type 2 diabetes.

    What are the study's limitations?

    Guideline.

    What does it say about Elawady's specific claim?

    Supports the T2D kernel of C-DIAB-03.

    Do the results apply to Germany and Europe?

    European guidance agrees.

    What can explicitly not be concluded from this study?

    Not applicable to T1D.

    Scientific details →

Studies with mixed or unclear results (6)

  • Pregnancy after weight-loss surgery

    Johansson K et al.. N Engl J Med 2015 · PMID 25714159 · DOI 10.1056/NEJMoa1405789
    Cohort studycited by the Tayebat archiveabstract checked

    Less gestational diabetes and fewer large babies, but more small babies.

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Pregnancy

    How was the study done?

    Matched cohort

    How many people, animals or samples were studied?

    670 exposed

    What was actually found?

    Mixed

    How large was the observed effect?

    SGA OR 2.20; GDM OR 0.25

    What do the results mean in everyday life?

    Pregnancy after surgery needs monitoring

    What are the study's limitations?

    Few deaths

    What does it say about Elawady's specific claim?

    Mixed

    Do the results apply to Germany and Europe?

    European

    What can explicitly not be concluded from this study?

    Causality

    Scientific details →

  • Swedish cohorts: more self-harm after surgery

    Neovius M et al.. Lancet Diabetes Endocrinol 2018 · PMID 29329975 · DOI 10.1016/S2213-8587(17)30437-0
    Cohort studycited by the Tayebat archivefull text, structured risk-of-bias assessment

    Self-harm and suicide were more frequent after surgery, but absolute risks were low.

    Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.

    Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Self-harm

    How was the study done?

    Matched cohorts

    How many people, animals or samples were studied?

    >40,000

    What was actually found?

    Higher risk

    How large was the observed effect?

    aHR 1.78-3.16

    What do the results mean in everyday life?

    Mental-health follow-up is needed

    What are the study's limitations?

    Observational; few suicides; self-selection; no sleeve gastrectomy

    What does it say about Elawady's specific claim?

    Supports risk; authors oppose general discouragement

    Do the results apply to Germany and Europe?

    European

    What can explicitly not be concluded from this study?

    Mechanism; that surgery shortens life overall; risk after sleeve

    Scientific details →

  • Nordic study: survival after obesity surgery

    Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048
    Cohort studyindependent cross-checkabstract checked★ key study

    Operated people died less often than non-operated people with obesity, but more often than the general population; suicide deaths were more frequent.

    Overall mortality lower (HR 0.63) but suicide HR 1.68.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Compare survival with two reference groups

    How was the study done?

    Registry cohort

    How many people, animals or samples were studied?

    505,258 (49,977 operated)

    What was actually found?

    HR 0.63 vs obese; SMR 1.94 vs general population

    How large was the observed effect?

    All-cause HR 0.63; suicide HR 1.68

    What do the results mean in everyday life?

    Surgery reduces but does not remove the excess risk of obesity

    What are the study's limitations?

    Older procedures; registry data

    What does it say about Elawady's specific claim?

    Contradicts "lethal", supports "still shorter life than general population"

    Do the results apply to Germany and Europe?

    Direct European data

    What can explicitly not be concluded from this study?

    Sleeve-specific long-term effects

    Scientific details →

  • Egyptian surgeon series: early safety of sleeve

    El Masry et al.. World J Surg 2023 · PMID 37548678 · DOI 10.1007/s00268-023-07123-0
    Case series / case reportindependent cross-checkabstract checked

    2 of 892 patients died within 30 days (0.22%).

    Egyptian series: 2 deaths in 892 sleeve operations (0.22%) - rare but not zero.

    Does the study support the specific claim? Partly · Methodological quality: low · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Report early complications

    How was the study done?

    Single-surgeon series

    How many people, animals or samples were studied?

    892

    What was actually found?

    Mortality 0.22%

    How large was the observed effect?

    2/892

    What do the results mean in everyday life?

    Early death is uncommon

    What are the study's limitations?

    One surgeon, no comparison

    What does it say about Elawady's specific claim?

    Shows deaths occur but are rare

    Do the results apply to Germany and Europe?

    Egyptian practice

    What can explicitly not be concluded from this study?

    Long-term outcomes

    Scientific details →

  • Meta-analysis: does surgery prolong life at every age?

    Pontiroli et al.. Obes Surg 2020 · PMID 32152843 · DOI 10.1007/s11695-020-04530-3
    Meta-analysisindependent cross-checkabstract checked

    Surgery was linked to fewer deaths in older patients, but in younger patients no clear survival benefit was shown.

    No proven mortality benefit below median age (OR 0.78, NS); external-cause deaths increased.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Age and mortality benefit

    How was the study done?

    Meta-analysis

    How many people, animals or samples were studied?

    not stated

    What was actually found?

    Benefit above median age only

    How large was the observed effect?

    OR 0.78 (young) vs 0.23 (older)

    What do the results mean in everyday life?

    Younger patients may not gain survival

    What are the study's limitations?

    Study-level age split

    What does it say about Elawady's specific claim?

    Partly supports a nuance, not "lethal"

    Do the results apply to Germany and Europe?

    Applicable

    What can explicitly not be concluded from this study?

    Net harm in young people

    Scientific details →

  • Cochrane review: surgery for obesity with type 2 diabetes

    Kiesswetter et al.. Cochrane Database Syst Rev 2026 · PMID 42610488 · DOI 10.1002/14651858.CD015622.pub2
    Meta-analysisindependent cross-checkabstract checked★ key study

    Trials show more weight loss and better blood sugar after surgery, but long-term data on complete diabetes remission, serious harms and deaths are very uncertain.

    RCT evidence on long-term mortality very uncertain (7 RCTs, n=520).

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Benefits/harms of MBS in T2D

    How was the study done?

    Cochrane NMA

    How many people, animals or samples were studied?

    15,282

    What was actually found?

    Weight and HbA1c better; remission/mortality very uncertain

    How large was the observed effect?

    RYGB weight MD -17%

    What do the results mean in everyday life?

    Surgery helps, but long-term certainty is limited

    What are the study's limitations?

    Few RCT participants

    What does it say about Elawady's specific claim?

    Partly supports erosion claim; does not show harm

    Do the results apply to Germany and Europe?

    Applicable

    What can explicitly not be concluded from this study?

    Precise long-term effects

    Scientific details →

Regional context

Germany / EU

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

Egypt

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

What applies in my country?

General scientific assessment

Mostly false As a general statement this is false: on average, bariatric surgery including sleeve is associated with lower mortality and longer life in severe obesity, and death from the operation itself is rare (about 1 in 2,000 sleeves); specific rare fatal risks (complications, suicide, alcohol) exist.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

  1. Long-term mortality after gastric bypass surgery.. Adams TD et al.. N Engl J Med 2007 · PMID 17715409 · DOI 10.1056/NEJMoa066603
  2. Perioperative safety in the longitudinal assessment of bariatric surgery.. Flum DR et al.. N Engl J Med 2009 · PMID 19641201 · DOI 10.1056/NEJMoa0901836
  3. Effects of bariatric surgery on mortality in Swedish obese subjects.. Sjöström L et al.. N Engl J Med 2007 · PMID 17715408 · DOI 10.1056/NEJMoa066254
  4. Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study.. Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449
  5. Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry.. Stenberg E et al.. Ann Surg 2014 · PMID 24374541 · DOI 10.1097/SLA.0000000000000431
  6. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.. Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
  7. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.. Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1
  8. Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.. Reges et al.. JAMA 2018 · PMID 29340677 · DOI 10.1001/jama.2017.20513
  9. Reduction in Long-term Mortality After Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Patients With Severe Obesity.. Courcoulas et al.. Ann Surg 2023 · PMID 34387200 · DOI 10.1097/SLA.0000000000005155
  10. Perioperative mortality in bariatric surgery: meta-analysis.. Robertson et al.. Br J Surg 2021 · PMID 34297806 · DOI 10.1093/bjs/znab245
  11. Overweight and obesity management (NICE guideline NG246; replaces CG189). NICE. National Institute for Health and Care Excellence 2025
  12. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care 2026 · PMID 41358882 · DOI 10.2337/dc26-S008
  13. Outcomes of pregnancy after bariatric surgery.. Johansson K et al.. N Engl J Med 2015 · PMID 25714159 · DOI 10.1056/NEJMoa1405789
  14. Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies.. Neovius M et al.. Lancet Diabetes Endocrinol 2018 · PMID 29329975 · DOI 10.1016/S2213-8587(17)30437-0
  15. Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study.. Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048
  16. Perioperative Morbidity and Mortality of Laparoscopic Sleeve Gastrectomy (LSG) in a Single-Surgeon Experience on 892 Patients Over 11 Years.. El Masry et al.. World J Surg 2023 · PMID 37548678 · DOI 10.1007/s00268-023-07123-0
  17. Compared with Controls, Bariatric Surgery Prevents Long-Term Mortality in Persons with Obesity Only Above Median Age of Cohorts: a Systematic Review and Meta-Analysis.. Pontiroli et al.. Obes Surg 2020 · PMID 32152843 · DOI 10.1007/s11695-020-04530-3
  18. Metabolic and bariatric surgery in adults with obesity and diabetes mellitus: a network meta-analysis.. Kiesswetter et al.. Cochrane Database Syst Rev 2026 · PMID 42610488 · DOI 10.1002/14651858.CD015622.pub2

← Back to overview